Volume 33, Issue 5 pp. 560-571

Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages

P. Lackner

Corresponding Author

P. Lackner

Department of Neurology and

Lackner Peter, Department of Neurology, Innsbruck Medical University, 6020 Innsbruck, Anichstrasse 35, Austria. Tel: +43 512 504 81011; Fax: +43 512 504 24243; E-mail: [email protected]Search for more papers by this author
C. Burger

C. Burger

Department of Neurology and

Search for more papers by this author
K. Pfaller

K. Pfaller

Division of Histology and Embryology, Innsbruck Medical University, Innsbruck, Austria, and

Search for more papers by this author
V. Heussler

V. Heussler

Department of Molecular Parasitology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany

Search for more papers by this author
R. Helbok

R. Helbok

Department of Neurology and

Search for more papers by this author
M. Morandell

M. Morandell

Department of Neurology and

Search for more papers by this author
G. Broessner

G. Broessner

Department of Neurology and

Search for more papers by this author
E. Tannich

E. Tannich

Department of Molecular Parasitology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany

Search for more papers by this author
E. Schmutzhard

E. Schmutzhard

Department of Neurology and

Search for more papers by this author
R. Beer

R. Beer

Department of Neurology and

Search for more papers by this author
First published: 18 April 2007
Citations: 49

Abstract

Cerebral malaria (CM) is associated with high mortality and morbidity as a certain percentage of survivors suffers from persistent neurological sequelae. The mechanisms leading to death and functional impairments are yet not fully understood. This study investigated biochemical and morphological markers of apoptosis in the brains of mice infected with Plasmodium berghei ANKA. Cleaved caspase-3 was detected in the brains of animals with clinical signs of CM and immunoreactivity directly correlated with the clinical severity of the disease. Caudal parts of the brain showed more intense immunoreactivity for cleaved caspase-3. Double-labelling experiments revealed processing of caspase-3 primarily in neurons and oligodendrocytes. These cells also exhibited apoptotic-like morphological profiles in ultrastructural analysis. Further, cleavage of caspase-3 was found in endothelial cells. In contrast to neurons and oligodendrocytes, apoptosis of endothelial cells already occurred in early stages of the disease. Our results are the first to demonstrate processing of caspase-3 in different central nervous system cells of animals with CM. Apoptosis of endothelial cells may represent a critical issue for the development of the disease in the mouse model. Neurological signs and symptoms might be attributable, at least in part, to apoptotic degeneration of neurons and glia in advanced stages of murine CM.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.